Skip to main content

This job has expired

You will need to login before you can apply for a job.

2023 Co-Op, Infectious Disease Research, Computational Immunology

Moderna, Inc.
Cambridge, MA
Start date
Mar 23, 2023

View more

Job Details

The Role:

The Moderna Research Co-op program is a 6-month experiential training program for students currently working towards an undergraduate or advanced degree in life/computer science.We are seeking talented and motivated students to be part of the vaccine discovery team for a wide range of disease targets. The Coop will work with other members of Infectious Disease Research group on the discovery and development of Modernas mRNA vaccine and immunotherapy candidates. You will work under the supervision of an experienced Moderna team member and have opportunities for cross-team collaboration, networking, and mentorship. You will learn how to apply programming skills for data collection, processing, statistical analysis, predictive modeling, and visualization to support program/project development. Also, you will learn about general experimental design and scientific strategy planning. The candidate will be part of the computational immunology team and support their own projects.

If you are bold, relentless, collaborative and obsess over learning, a co-op at Moderna will help augment your research experience and accelerate your career.

Our summer/fall co-op program is from July 17 December 15, 2023. All applicants must be available for the entire duration of the program.

Heres What Youll Do:

  • Develop analytics pipelines for different types of high-dimensional data, including but not limited to data from next generation sequencing, flow cytometry, mass spectrometry, ELISA, Luminex, or imaging.

  • Develop customized code in R or python to streamline data collection and management.

  • Implement and benchmark the existing statistical algorithms for specific data analysis as well as predictive machine-learning modeling.

  • Manage and improve computational immunology teams code and data repository and training documents.

  • Align with infectious disease research group members for specific data analysis or data visualization plan and deliver the results

  • Work with the IT teams to establish and maintain an automated workflow for data acquisition and processing in a cloud-based environment.

  • Prepare documents and present strategy, results, project updates, and summaries.

Heres What Youll Bring to the Table:

  • Currently enrolled in an undergraduate or advanced degree program in computational biology, bioinformatics, statistics, computer sciences, bioengineering or related degree.

  • Good coding experience in R or Python is required

  • Experience in cloud-based computing environment and data science development platforms, such as GitLab, Jupyter, R shiny, Anaconda, and Docker container, is needed.

  • Experience in omic or flow cytometry data analysis is a plus.

  • Basic understanding of Biology and Immunology is a plus.

  • Curious in exploring new discovery, bold in trying new ideas, willing to work collectively and relentless in pursuing successful outcomes.

  • Self-motivated and possess the desire to drive a project to completion. Flexible and capable of working in a fast-paced, team-oriented environment.

  • Legal authorization to work in the US

Moderna is pleased to provide you with an innovative suite of benefits, including:

  • Free premium access to meditation and mindfulness classes
  • Free parking or subsidized commuter passes
  • Generous paid time off, including:
    Vacation, sick time and holidays
    Volunteer time to participate within your community
    Discretionary year-end shutdown
  • Location-specific perks and extras!

Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19 and receive a booster shot once eligible. Newly hired employees must be vaccinated and boosted prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated or receive a booster where it is not an undue hardship to the company to do so as provided under federal, state, and local law.

About Moderna

In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit

Moderna is a smoke-free, alcohol-free and drug-free work environment.

Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a persons race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.



Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

mRNA is now a turning point in the history of science, medicine, technology, even humankind itself. With this breakthrough discovery, many of the world’s biggest and most challenging medical problems are no longer a question of “how?” but merely a question of “when?”

Come with us as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.


Stock Symbol:


Stock Exchange:



Facebook  Instagram  Twitter


Company info
200 Technology Square
Cambridge, MA

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert